HC Wainwright & Co. Reiterates Buy on FibroBiologics, Maintains $5 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Matthew Caufield reiterates FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $5 price target.